Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 119283 - 119283
Published: Dec. 1, 2024
Language: Английский
Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: unknown, P. 119283 - 119283
Published: Dec. 1, 2024
Language: Английский
Journal of Ethnopharmacology, Journal Year: 2024, Volume and Issue: 325, P. 117846 - 117846
Published: Jan. 30, 2024
Language: Английский
Citations
6International Journal of Molecular Sciences, Journal Year: 2022, Volume and Issue: 23(24), P. 16093 - 16093
Published: Dec. 17, 2022
Remyelination therapies, which are currently under development, have a great potential to delay, prevent or even reverse disability in multiple sclerosis patients. Several models available study the effectiveness of novel compounds vivo, among is cuprizone model. This model characterized by toxin-induced demyelination, followed endogenous remyelination after cessation intoxication. Due its high reproducibility and ease use, this enjoys popularity various research industrial groups. In review article, we will summarize recent findings using discuss some identified promote
Language: Английский
Citations
22Frontiers in Molecular Neuroscience, Journal Year: 2023, Volume and Issue: 16
Published: March 16, 2023
Research has long centered on the pathophysiology of pain. The Transient Receiver Potential (TRP) protein family is well known for its function in pain, and extensive study been done this area. One significant mechanisms pain etiology analgesia that lacks a systematic synthesis review ERK/CREB (Extracellular Signal-Regulated Kinase/CAMP Response Element Binding Protein) pathway. pathway-targeting analgesics may also cause variety adverse effects call specialized medical care. In review, we systematically compiled mechanism pathway process analgesia, as potential nervous system brought by inhibition analgesic drugs, suggested corresponding solutions.
Language: Английский
Citations
12Multiple Sclerosis and Related Disorders, Journal Year: 2025, Volume and Issue: 95, P. 106319 - 106319
Published: Feb. 8, 2025
Language: Английский
Citations
0Journal of Advanced Research, Journal Year: 2025, Volume and Issue: unknown
Published: April 1, 2025
Language: Английский
Citations
0International Immunopharmacology, Journal Year: 2025, Volume and Issue: 158, P. 114800 - 114800
Published: May 9, 2025
Language: Английский
Citations
0Phytomedicine, Journal Year: 2023, Volume and Issue: 123, P. 155248 - 155248
Published: Dec. 7, 2023
Language: Английский
Citations
9Neuroscience, Journal Year: 2023, Volume and Issue: 538, P. 1 - 10
Published: Oct. 31, 2023
With the deepening of population aging, treatment cognitive impairment and dementia is facing increasing challenges. Vascular (VaD) a dysfunction caused by brain blood flow damage one most common causes after Alzheimer's disease. White matter in patients with chronic ischemic often occurs before impairment, its pathological changes include leukoaraiosis, myelin destruction oligodendrocyte death. The pathophysiology vascular complex, involving variety neuronal lesions. current proposed mechanisms calcium overload, oxidative stress, nitrative stress inflammatory damage, which can lead to hypoxia-ischemia demyelination. Oligodendrocytes are only myelinating cells central nervous system closely associated VaD. In this review article, we intend further discuss role oligodendrocytes white injury VaD development anti-myelin target drugs.
Language: Английский
Citations
8Journal of Ethnopharmacology, Journal Year: 2023, Volume and Issue: 309, P. 116364 - 116364
Published: March 13, 2023
Language: Английский
Citations
6Pharmacological Research, Journal Year: 2024, Volume and Issue: unknown, P. 107533 - 107533
Published: Nov. 1, 2024
Language: Английский
Citations
2